Heilongjiang ZBD Pharmaceutical Co Ltd Cash Flow Quality Index
Heilongjiang ZBD Pharmaceutical Co Ltd cash flow quality index. Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Cash Flow Quality Index of -3.54x as of March 2025. Operating cash flow of CN¥-266.69 Million is below net income of CN¥75.30 Million, suggesting accrual-heavy earnings not yet converted to cash. See 603567 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2024)
Cash flow quality index of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2024. Historical Cash Flow Quality Index for Heilongjiang ZBD Pharmaceutical Co Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 603567 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Heilongjiang ZBD Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2011–2024)
Heilongjiang ZBD Pharmaceutical Co Ltd cash flow quality index by year from 2011 to 2024. Year-by-year earnings quality comparison for Heilongjiang ZBD Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 603567 cash generation efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.38x | CN¥164.31 Million | CN¥436.39 Million | ▲ +138.9% |
| 2023 | -0.97x | CN¥-457.90 Million | CN¥472.74 Million | ▲ +43.4% |
| 2022 | -1.71x | CN¥-326.79 Million | CN¥190.88 Million | ▼ -31.3% |
| 2021 | -1.30x | CN¥-433.94 Million | CN¥332.76 Million | ▼ -467.7% |
| 2020 | 0.35x | CN¥155.18 Million | CN¥437.50 Million | ▼ -34.8% |
| 2019 | 0.54x | CN¥220.92 Million | CN¥405.84 Million | ▼ -31.3% |
| 2018 | 0.79x | CN¥367.40 Million | CN¥463.40 Million | ▼ -51.4% |
| 2017 | 1.63x | CN¥853.19 Million | CN¥523.20 Million | ▲ +5017.7% |
| 2016 | 0.03x | CN¥15.83 Million | CN¥496.66 Million | ▲ +105.7% |
| 2015 | -0.56x | CN¥-323.90 Million | CN¥579.77 Million | ▼ -167.1% |
| 2014 | 0.83x | CN¥386.32 Million | CN¥464.05 Million | ▲ +102.5% |
| 2013 | 0.41x | CN¥174.68 Million | CN¥424.82 Million | ▲ +2.5% |
| 2012 | 0.40x | CN¥154.25 Million | CN¥384.61 Million | ▲ +13.4% |
| 2011 | 0.35x | CN¥104.71 Million | CN¥296.06 Million | — |